These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 26159306)

  • 1. MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases.
    Hashimoto M; Bacman SR; Peralta S; Falk MJ; Chomyn A; Chan DC; Williams SL; Moraes CT
    Mol Ther; 2015 Oct; 23(10):1592-9. PubMed ID: 26159306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease.
    Blok MJ; Spruijt L; de Coo IF; Schoonderwoerd K; Hendrickx A; Smeets HJ
    J Med Genet; 2007 Apr; 44(4):e74. PubMed ID: 17400793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MitoTALEN reduces mutant mtDNA load and restores tRNA
    Bacman SR; Kauppila JHK; Pereira CV; Nissanka N; Miranda M; Pinto M; Williams SL; Larsson NG; Stewart JB; Moraes CT
    Nat Med; 2018 Nov; 24(11):1696-1700. PubMed ID: 30250143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of antigenomic therapy of mitochondrial diseases by mitochondrially addressed RNA targeting a pathogenic point mutation in mitochondrial DNA.
    Tonin Y; Heckel AM; Vysokikh M; Dovydenko I; Meschaninova M; Rötig A; Munnich A; Venyaminova A; Tarassov I; Entelis N
    J Biol Chem; 2014 May; 289(19):13323-34. PubMed ID: 24692550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mitoTev-TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels.
    Pereira CV; Bacman SR; Arguello T; Zekonyte U; Williams SL; Edgell DR; Moraes CT
    EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30012581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
    Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
    Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs.
    Bacman SR; Williams SL; Pinto M; Peralta S; Moraes CT
    Nat Med; 2013 Sep; 19(9):1111-3. PubMed ID: 23913125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations.
    Gammage PA; Rorbach J; Vincent AI; Rebar EJ; Minczuk M
    EMBO Mol Med; 2014 Apr; 6(4):458-66. PubMed ID: 24567072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin rescues mitochondrial dysfunction in cells carrying the m.8344A > G mutation in the mitochondrial tRNA
    Capristo M; Del Dotto V; Tropeano CV; Fiorini C; Caporali L; La Morgia C; Valentino ML; Montopoli M; Carelli V; Maresca A
    Mol Med; 2022 Aug; 28(1):90. PubMed ID: 35922766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating Mitochondrial DNA Heteroplasmy with Mitochondrially Targeted Endonucleases.
    Mikhailov N; Hämäläinen RH
    Ann Biomed Eng; 2024 Sep; 52(9):2627-2640. PubMed ID: 36001180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic rescue in pluripotent cells from patients with mtDNA disease.
    Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S
    Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis.
    Park JS; Sharma LK; Li H; Xiang R; Holstein D; Wu J; Lechleiter J; Naylor SL; Deng JJ; Lu J; Bai Y
    Hum Mol Genet; 2009 May; 18(9):1578-89. PubMed ID: 19208652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes / myoclonus epilepsy with ragged-red fibers /Leigh overlap syndrome caused by mitochondrial DNA 8344A>G mutation].
    Hou Y; Zhao XT; Xie ZY; Yuan Y; Wang ZX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):851-855. PubMed ID: 33047718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches.
    Nissanka N; Moraes CT
    EMBO Rep; 2020 Mar; 21(3):e49612. PubMed ID: 32073748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo.
    Zekonyte U; Bacman SR; Smith J; Shoop W; Pereira CV; Tomberlin G; Stewart J; Jantz D; Moraes CT
    Nat Commun; 2021 May; 12(1):3210. PubMed ID: 34050192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise intolerance and developmental delay associated with a novel mitochondrial ND5 mutation.
    Fang H; Shi H; Li X; Sun D; Li F; Li B; Ding Y; Ma Y; Liu Y; Zhang Y; Shen L; Bai Y; Yang Y; Lu J
    Sci Rep; 2015 May; 5():10480. PubMed ID: 26014388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced mitochondrial DNA editing in mice using nuclear-exported TALE-linked deaminases and nucleases.
    Lee S; Lee H; Baek G; Namgung E; Park JM; Kim S; Hong S; Kim JS
    Genome Biol; 2022 Oct; 23(1):211. PubMed ID: 36224582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial DNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression in cultured cells of patients with MERRF syndrome.
    Wu SB; Ma YS; Wu YT; Chen YC; Wei YH
    Mol Neurobiol; 2010 Jun; 41(2-3):256-66. PubMed ID: 20411357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial respiratory chain disorders in the Old Order Amish population.
    Ghaloul-Gonzalez L; Goldstein A; Walsh Vockley C; Dobrowolski SF; Biery A; Irani A; Ibarra J; Morton DH; Mohsen AW; Vockley J
    Mol Genet Metab; 2016 Aug; 118(4):296-303. PubMed ID: 27344355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of chemically modified oligonucleotides targeting a pathogenic mutation in human mitochondrial DNA.
    Tonin Y; Heckel AM; Dovydenko I; Meschaninova M; Comte C; Venyaminova A; Pyshnyi D; Tarassov I; Entelis N
    Biochimie; 2014 May; 100():192-9. PubMed ID: 23994754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.